Dr Reddys Laboratories (RDY) Change in Cash (2009 - 2026)

Dr Reddys Laboratories has reported Change in Cash for 18 years, with the latest figure at -$44.4 million in Q2 2026.

• On a quarterly basis, Change in Cash rose 34.03% year-over-year to -$44.4 million in Q2 2026; TTM through Jun 2026 was $16.3 million, a 63.78% decrease from a year earlier, with the FY2026 full-year figure at -$5.0 million, down 105.88% from the prior year.
• Change in Cash was -$44.4 million for Q2 2026 at Dr Reddys Laboratories, down from -$41.6 million in the prior quarter.
• The five-year high for Change in Cash was $124.7 million in Q1 2024, with the low at -$202.7 million in Q4 2023.
• Average Change in Cash over 5 years is -$9.5 million, with a median of $1.7 million recorded in 2025.
• The sharpest annual moves came in 2023 and 2024: Change in Cash plunged 548.32% in 2023, then surged 2714.55% in 2024.
• Over 5 years, Change in Cash stood at -$31.3 million in 2022, then slumped by 548.32% to -$202.7 million in 2023, then jumped by 110.24% to $20.8 million in 2024, then surged by 354.21% to $94.2 million in 2025, then slumped by 147.16% to -$44.4 million in 2026.
• The last three Change in Cash figures came in at -$44.4 million (Q2 2026), -$41.6 million (Q1 2026), and $94.2 million (Q4 2025), per Business Quant data.